Advancing Global Health Through Breakthrough Diagnostics and Life-Changing Biopharmaceuticals

Abdullah Mahmud

Executive Chairman - BEng (Hons) (University of Greenwich)

Abdullah brings over 18 years of international experience in scaling business development and regulated manufacturing. He has spearheaded HA TECH's global expansion, exporting products to over 25 countries and earning the company an NSW Export Award.

Abdullah oversees sales and marketing, public relations, finance, and manufacturing scale-up, demonstrating comprehensive leadership in driving international growth.

Dr. Hani Nur

Managing Director - PhD- University of Greenwich, UK

Dr. Hani Nur is a biotechnology executive specializing in the development and commercialization of medical devices and biopharmaceuticals. Since 2019, Dr. Nur has led HA TECH as Managing Director, overseeing strategic growth and global market expansion.

Under Dr. Nur’s leadership, HA TECH has advanced a portfolio of 30 In-Vitro Diagnostic (IVD) medical devices, achieving regulatory clearances including TGA (Australia), CE Mark (EU), and independent approvals across Asia. Commercialization efforts are also underway for several biopharmaceutical products.

Dr. Nur’s expertise spans QMS implementation across R&D and manufacturing, and international regulatory strategy. Innovation is driven through lean systems and collaborative execution to deliver scalable, high-quality healthcare solutions.

Dr Peter Valtchev

PhD (University of Sydney, Australia)

Dr. Valtchev works as Chief Technology Officer for HA TECH’s Biological division for Insulin analogues and GLP based drugs development. He works with department of Chemical and Biomolecular Engineering at the University of Sydney and has extensive experience in the fields of drug discovery and drug development, drug delivery, tissue engineering, therapeutic drug monitoring, metabolism and pharmacokinetics

He has more than 50 publications, 4 patents and his H-index is 18 reflecting work on multi-disciplinary projects involving therapeutic proteins, natural bioactive compounds, tissue scaffolds and drug delivery devices. Peter has more than 14 years of experience in the pharmaceutical and clinical diagnostics industry.

Professor Martin Snowden, Technical Advisor

PhD, CSci, CChem, FRSC, PFHEA (UK)

Prof. Martin Snowden is Pro Vice-chancellor and head of the Faculty of Engineering and Science at the University of Greenwich in London, UK. He has a distinguished track record of high-quality published output including the publication of17 Q1 Pharmaceutical Science papers since 2014 (h-index 41).

Professor Snowden is a Principal Fellow of the Higher Education Academy and an Eminent Fellow of the Academy of Pharmaceutical Sciences. He provides strategic leadership for all the International work of the University including its very successful Trans National Education provision. He also provides leadership and strategic development to 4 major academic disciplines including Engineering, Pharmacy, Science and the Natural Resources Institute. Professor Snowden has many successful partnerships with leading Pharmaceutical companies including Pfizer and GSK.

Prof. Shariff Enamul Kabir, Technical Advisor

PhD (University College London, UK)

Prof. Kabir has been a leading figure in chemical research for over 37 years, with significant contributions across organometallic cluster chemistry, bioinorganic chemistry, and polymer composites. His pioneering work on polynuclear metal sites has advanced understanding of heterogeneous catalytic systems. Notably, his research has enabled industrial applications for sulfur removal from petroleum-based feedstocks—an achievement with both environmental and commercial impact.

Prof. Kabir’s international collaborations span institutions such as University College London, California State University Northridge, University of Montana, Freiburg University, and Lund University. With 324 publications in prestigious journals, he is also a respected reviewer and mentor, fostering diversity and research excellence. Many of his trainees now contribute to academia and industry globally.

Garry Payne

Executive Vice President, International Business Development

Born in Montreal, Canada, Mr. Payne brings over 30 years of global experience in advancing public safety and emergency response systems through innovative technologies and strategic advisory. His career spans collaborations with senior government officials, emergency services, and IT organizations across more than 20 countries, including the U.S., France, Qatar, China, and Brazil.

Mr. Payne is widely recognized for his ability to design and implement pragmatic, measurable solutions for mission-critical environments. He is the architect behind Malaysia’s national emergency response system, MERS 999, one of the most advanced systems globally. His doctrine for sustainable emergency management programs has been adopted in multiple jurisdictions.

A long-time resident of Kuala Lumpur, Mr. Payne is committed to bringing international best practices to Asia. He has served as Associate Director of the International Academies of Emergency Dispatch (IAED), Goodwill Ambassador for NENA, and Chair of the International Committee for ICert.

Known for his thought leadership, Mr. Payne is a frequent keynote speaker and a respected voice in the global emergency response community. His mission remains clear: to make the world safer by integrating technology with human-centered solutions.